R. Chiarle, C. Voena, C. Ambrogio, R. Piva, and G. Inghirami, The anaplastic lymphoma kinase in the pathogenesis of cancer, Nature Reviews Cancer, vol.159, issue.1, pp.11-23, 2008.
DOI : 10.1002/ijc.21490

R. Palmer, E. Vernersson, C. Grabbe, and B. Hallberg, Anaplastic lymphoma kinase: signalling in development and disease, Biochemical Journal, vol.62, issue.3, pp.345-361, 2009.
DOI : 10.1182/blood-2003-04-1050

B. Hallberg and R. Palmer, Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology, Nature Reviews Cancer, vol.17, issue.10, pp.685-700, 2013.
DOI : 10.1038/nrc3580

H. Mano, ALKoma: A Cancer Subtype with a Shared Target, Cancer Discovery, vol.2, issue.6, pp.495-502, 2012.
DOI : 10.1158/2159-8290.CD-12-0009

I. Janoueix-lerosey, G. Schleiermacher, and O. Delattre, Molecular pathogenesis of peripheral neuroblastic tumors, Oncogene, vol.23, issue.11, pp.1566-1579, 2010.
DOI : 10.1158/0008-5472.CAN-06-4443

D. Brouwer, S. , D. Preter, K. Kumps, C. Zabrocki et al., Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification, Clinical Cancer Research, vol.16, issue.17, pp.4353-4362, 2010.
DOI : 10.1158/1078-0432.CCR-09-2660

Y. Mosse, M. Laudenslager, L. Longo, K. Cole, A. Wood et al., Identification of ALK as a major familial neuroblastoma predisposition gene, Nature, vol.25, issue.7215, pp.930-935, 2008.
DOI : 10.1038/nature07261

I. Janoueix-lerosey, D. Lequin, L. Brugieres, A. Ribeiro, L. De-pontual et al., Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma, Nature, vol.40, issue.7215, pp.967-970, 2008.
DOI : 10.1038/nature07398

D. Pontual, L. Kettaneh, D. Gordon, C. Oufadem, M. Boddaert et al., Germline gain-of-function mutations of ALK disrupt central nervous system development, Human Mutation, vol.9, issue.3, pp.272-278, 2011.
DOI : 10.1002/humu.21442

URL : https://hal.archives-ouvertes.fr/hal-00616287

T. Iwahara, J. Fujimoto, D. Wen, R. Cupples, N. Bucay et al., Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system, Oncogene, vol.14, issue.4, pp.439-449, 1997.
DOI : 10.1038/sj.onc.1200849

S. Morris, C. Naeve, P. Mathew, P. James, M. Kirstein et al., ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK), Oncogene, vol.14, issue.18, pp.2175-88, 1997.
DOI : 10.1038/sj.onc.1201062

E. Vernersson, N. Khoo, M. Henriksson, G. Roos, R. Palmer et al., Characterization of the expression of the ALK receptor tyrosine kinase in mice, Gene Expression Patterns, vol.6, issue.5, pp.448-61, 2006.
DOI : 10.1016/j.modgep.2005.11.006

E. Bazigou, H. Apitz, J. Johansson, C. Lorén, E. Hirst et al., Anterograde Jelly belly and Alk Receptor Tyrosine Kinase Signaling Mediates Retinal Axon Targeting in Drosophila, Cell, vol.128, issue.5, pp.961-975, 2007.
DOI : 10.1016/j.cell.2007.02.024

J. Gouzi, A. Moressis, J. Walker, A. Apostolopoulou, R. Palmer et al., The Receptor Tyrosine Kinase Alk Controls Neurofibromin Functions in Drosophila Growth and Learning, PLoS Genetics, vol.157, issue.813, p.1002281, 2011.
DOI : 10.1371/journal.pgen.1002281.s008

L. Cheng, A. Bailey, S. Leevers, T. Ragan, P. Driscoll et al., Anaplastic Lymphoma Kinase Spares Organ Growth during Nutrient Restriction in Drosophila, Cell, vol.146, issue.3, pp.435-447, 2011.
DOI : 10.1016/j.cell.2011.06.040

J. Bilsland, A. Wheeldon, A. Mead, P. Znamenskiy, S. Almond et al., Behavioral and Neurochemical Alterations in Mice Deficient in Anaplastic Lymphoma Kinase Suggest Therapeutic Potential for Psychiatric Indications, Neuropsychopharmacology, vol.39, issue.3, pp.685-700, 2008.
DOI : 10.1006/mcne.1997.0638

J. Weiss, C. Xue, T. Benice, L. Xue, S. Morris et al., Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase: Functions and genetic interactions in learning, memory and adult neurogenesis, Pharmacology Biochemistry and Behavior, vol.100, issue.3, pp.566-574, 2012.
DOI : 10.1016/j.pbb.2011.10.024

A. Lasek, J. Lim, C. Kliethermes, K. Berger, J. G. Brush et al., An Evolutionary Conserved Role for Anaplastic Lymphoma Kinase in Behavioral Responses to Ethanol, PLoS ONE, vol.100, issue.7, p.22636, 2011.
DOI : 10.1371/journal.pone.0022636.s004

S. Bresler, A. Wood, E. Haglund, J. Courtright, L. Belcastro et al., Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma, Sci Transl Med Dis. Model. Mech, vol.3, issue.6, pp.373-382, 2011.

T. Bachetti, D. Paolo, D. , D. Lascio, S. Mirisola et al., PHOX2B-Mediated Regulation of ALK Expression: In Vitro Identification of a Functional Relationship between Two Genes Involved in Neuroblastoma, PLoS ONE, vol.5, issue.10, 2010.
DOI : 10.1371/journal.pone.0013108.t002

N. Cheung and M. Dyer, Neuroblastoma: developmental biology, cancer genomics and immunotherapy, Nature Reviews Cancer, vol.10, issue.6, pp.397-411, 2013.
DOI : 10.1038/nrc3526

V. Dubreuil, N. Ramanantsoa, D. Trochet, V. Vaubourg, J. Amiel et al., A human mutation in Phox2b causes lack of CO2 chemosensitivity, fatal central apnea, and specific loss of parafacial neurons, Proceedings of the National Academy of Sciences, vol.105, issue.3, pp.1067-72, 2008.
DOI : 10.1073/pnas.0709115105

S. Brown, P. Chambon, M. De-angelis, and E. Consortium, EMPReSS: standardized phenotype screens for functional annotation of the mouse genome, Nature Genetics, vol.25, issue.11, p.1155, 2005.
DOI : 10.1038/ng0904-925

H. Meziane, A. Ouagazzal, A. L. Wietrzych, M. Krezel, and W. , Estrous cycle effects on behavior of C57BL/6J and BALB/cByJ female mice: implications for phenotyping strategies, Genes, Brain and Behavior, vol.72, issue.Suppl 2, pp.192-200, 2007.
DOI : 10.1111/j.1601-183X.2006.00249.x

URL : https://hal.archives-ouvertes.fr/hal-00190951

S. Mandillo, V. Tucci, S. Hölter, H. Meziane, M. Banchaabouchi et al., Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study, Physiological Genomics, vol.34, issue.3, pp.243-255, 2008.
DOI : 10.1152/physiolgenomics.90207.2008

S. Lamprianou, N. Vacaresse, Y. Suzuki, H. Meziane, J. Buxbaum et al., Receptor Protein Tyrosine Phosphatase ?? Is a Marker for Pyramidal Cells and Sensory Neurons in the Nervous System and Is Not Necessary for Normal Development, Molecular and Cellular Biology, vol.26, issue.13, pp.5106-5119, 2006.
DOI : 10.1128/MCB.00101-06

M. Paques, J. Guyomard, M. Simonutti, M. Roux, S. Picaud et al., Panretinal, High-Resolution Color Photography of the Mouse Fundus, Investigative Opthalmology & Visual Science, vol.48, issue.6, pp.2769-2774, 2007.
DOI : 10.1167/iovs.06-1099

A. Dady, C. Blavet, and J. Duband, Timing and kinetics of E- to N-cadherin switch during neurulation in the avian embryo, Developmental Dynamics, vol.14, issue.Suppl 1, pp.1333-1349, 2012.
DOI : 10.1002/dvdy.23813

S. Dauger, E. Durand, G. Cohen, H. Lagercrantz, J. Changeux et al., Control of breathing in newborn mice lacking the beta-2 nAChR subunit, Acta Physiologica Scandinavica, vol.17, issue.2, pp.205-212, 2004.
DOI : 10.1016/S1569-9048(03)00076-4

URL : https://hal.archives-ouvertes.fr/pasteur-00163485

B. Matrot, E. Durand, S. Dauger, G. Vardon, C. Gaultier et al., Automatic classification of activity and apneas using whole body plethysmography in newborn mice, Journal of Applied Physiology, vol.98, issue.1
DOI : 10.1152/japplphysiol.00803.2004

N. Ramanantsoa, V. Vaubourg, S. Dauger, B. Matrot, G. Vardon et al., Ventilatory response to hyperoxia in newborn mice heterozygous for the transcription factor Phox2b, AJP: Regulatory, Integrative and Comparative Physiology, vol.290, issue.6, pp.1691-1696, 2006.
DOI : 10.1152/ajpregu.00875.2005

A. Cazes, L. Lopez-delisle, K. Tsarovina, C. Pierre-eugène, D. Preter et al., Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma, Oncotarget, vol.5, issue.9, pp.2688-2702, 2014.
DOI : 10.18632/oncotarget.1883